Tenofovir alafenamide (TAF)

Published February 2016; Updated October 2017
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-01-09
Selected Reference
9. Gallant J, Brunetta J, Crofoot G, et al. Efficacy and safety of switching to a single-tablet regimen of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in HIV-1/hepatitis B coinfected adults. J Acquir Immune Defic Syndr. 2016 May 11. [Epub ahead of print]